Nanjing, March 23, 2022, Nanjing Zenshine Pharmaceuticals Co., Ltd.(Zenshine Pharma) announced that three presentations for programs ZX-101A, ZX-4081 and ZX-8177 from its oncology pipeline have been accepted by the American Association for Cancer Research (AACR) Annual Meeting 2022. These abstracts are available online now:
· Program: ZX-101A(PI3Kδ/γ dual inhibitor)
A Phase 1/2a Study of a PI3Kδγ dual inhibitor ZX-101A in patients with advanced solid tumors
Abstract number: CT526
Session: Phase I Trials in Progress
Date and Time: April 8, 2022, 12:00 PM - 1:00 PM
https://www.abstractsonline.com/pp8/#!/10517/presentation/20337
· Program: ZX-4081(PI3Kγ Inhibitor)
A phase 1 study of selective PI3Kγ inhibitor ZX-4081 in patients with advanced solid tumors
Abstract number: 6240
Session: Pharmacology, Pharmacogenetics, and Pharmacogenomics
Date and Time: April 8, 2022, 12:00 PM - 1:00 PM
https://www.abstractsonline.com/pp8/#!/10517/presentation/20488
· Program: ZX-8177(ENPP1 inhibitor)
ENPP1 inhibitor ZX-8177 enhances anti-tumor activity of conventional therapies by modulating tumor microenvironment
Abstract number: 5486
Session: Small Molecule Therapeutic Agents
Date and Time: April 8, 2022, 12:00 PM - 1:00 PM
https://www.abstractsonline.com/pp8/#!/10517/presentation/18631
About Zenshine Pharma
Zenshine Pharma is a clinical stage biopharmaceutical company, focused on small molecule therapeutics in the areas of cancer, viral infection and inflammation. Our mission is to apply the best science to serve patients. Zenshine leverages the team’s extensive expertise and experience in developing proprietary chemical entities with well-defined differentiation to benefit the patients. By targeting key biological pathways to disrupt virus replication, directly block tumor growth and enhance anti-tumor immune responses, Zenshine commits to providing bench-side to bed-side solutions and delivering the best-in-class or first-in-class therapeutics.
About AACR
The American Association for Cancer Research (AACR) is the first and largest cancer research organization dedicated to accelerating the conquest of cancer. Covering the most cutting-edge advances and regarded globally as the very pinnacle of cancer research, the AACR Annual Meeting is one of the largest and most anticipated scientific events in the cancer research field globally. AACR Annual Meeting 2022 will be held in New Orleans, USA on April 8th to 13th.
